Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Astrocytoma × encorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Melanoma 9 Neoplasm Metastasis 3 Neoplasms 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Solid Tumors Harboring a BRAF V600 Mutation 1 Skin Neoplasms 1 Skin Diseases 1 Pancreatic Neoplasms 1 Lymphatic Metastasis 1 Hematologic Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Astrocytoma 1

Interventions

Temozolomide 27 Bevacizumab 14 Radiotherapy 12 antineoplaston AS 2-1 8 antineoplaston A10 8 Erlotinib Hydrochloride 6 Radiation 5 Everolimus 5 Radiotherapy, Intensity-Modulated 4 palbociclib 3 Vorinostat 3 Sunitinib 3 Lomustine 3 Carmustine 3 Carboplatin 3 selinexor 2 poly ICLC 2 etoposide phosphate 2 cabozantinib 2 Radiotherapy, Conformal 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Immunoglobulin G 2 Donepezil 2 Disulfides 2 Dasatinib 2 Corticotropin-Releasing Hormone 2 Cancer Vaccines 2 Adjuvants, Immunologic 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡